Jazz Pharmaceuticals plc — Director's Dealing 2013

Jun 4, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2013-06-03

Reporting Person: COZADD BRUCE C (Director, Chairman and CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-06-03	Ordinary Shares	M	1452	$11.48	Acquired	662691	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-06-03	Incentive Stock Option (right to buy)	$11.48	M	1452	Disposed	2020-03-07	Ordinary Shares (1452)	Direct

Footnotes

F1: Includes 596 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on May 31, 2013.

F2: Following the reported transaction, the remaining ordinary shares subject to this option vest with respect to 5,081 shares in seven equal monthly installments from June 8, 2013 to December 8, 2013 and with respect to 8,710 shares in three equal monthly installments from January 8, 2014 to March 8, 2014.